All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Reported results | 2004-000299-15 | A double-blind dose-response phase II, multicentre study of radium-223 (Alpharadrin ™) for the palliation of painful bone metastases in hormone refractory prostate cancer patients. | 2009-10-06 | due-trials |
| Reported results | 2005-003680-22 | A double blind, randomised, dose finding, repeat dose, phase II, multicentre study of Alpharadin TM for the treatment of patients with hormone refractory prostate cancer and skeletal metastases. | 2009-12-04 | due-trials |
| Reported results | 2007-006195-11 | A double blind, randomised, multiple dose, phase III, multicentre study of AlpharadinTM in the treatment of patients with hormone-refractory prostate cancer with skeletal metastases | 2014-02-13 | due-trials |
| Reported results | 2009-012189-30 | An open-label Phase IIa, non-randomised, study of Alpharadin in breast cancer patients with bone dominant disease who are no longer considered suitable for endocrine therapy | 2012-02-16 | due-trials |